These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 20568483)

  • 1. Japanese encephalitis vaccine. Useful for selected adult travellers.
    Prescrire Int; 2010 Apr; 19(106):59-61. PubMed ID: 20568483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chimeric live, attenuated vaccine against Japanese encephalitis (ChimeriVax-JE): phase 2 clinical trials for safety and immunogenicity, effect of vaccine dose and schedule, and memory response to challenge with inactivated Japanese encephalitis antigen.
    Monath TP; Guirakhoo F; Nichols R; Yoksan S; Schrader R; Murphy C; Blum P; Woodward S; McCarthy K; Mathis D; Johnson C; Bedford P
    J Infect Dis; 2003 Oct; 188(8):1213-30. PubMed ID: 14551893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IMOJEV(®): a Yellow fever virus-based novel Japanese encephalitis vaccine.
    Appaiahgari MB; Vrati S
    Expert Rev Vaccines; 2010 Dec; 9(12):1371-84. PubMed ID: 21105774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Phase 2 study of a purified, inactivated virus vaccine to prevent Japanese encephalitis.
    Lyons A; Kanesa-thasan N; Kuschner RA; Eckels KH; Putnak R; Sun W; Burge R; Towle AC; Wilson P; Tauber E; Vaughn DW
    Vaccine; 2007 Apr; 25(17):3445-53. PubMed ID: 17241714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study.
    Kaltenböck A; Dubischar-Kastner K; Eder G; Jilg W; Klade C; Kollaritsch H; Paulke-Korinek M; von Sonnenburg F; Spruth M; Tauber E; Wiedermann U; Schuller E
    Vaccine; 2009 Jul; 27(33):4483-9. PubMed ID: 19486955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Japanese encephalitis: update on vaccines and vaccine recommendations.
    Wilder-Smith A; Halstead SB
    Curr Opin Infect Dis; 2010 Oct; 23(5):426-31. PubMed ID: 20581670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Study on the strategy of Japanese encephalitis immunization using live attenuated vaccine combined with inactivated vaccine].
    Ma FB; Zheng L; Bi C; Tao H; Zhou YL; Zhang JL; Tang FY; Xie P; Zheng CZ; Peng WB; Jiang RJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Feb; 24(2):113-5. PubMed ID: 12697111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Japanese encephalitis vaccine in travelers.
    Jelinek T
    Expert Rev Vaccines; 2008 Jul; 7(5):689-93. PubMed ID: 18564023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ixiaro: a new vaccine against Japanese encephalitis.
    Jelinek T
    Expert Rev Vaccines; 2009 Nov; 8(11):1501-11. PubMed ID: 19863241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized, double-blind, placebo-controlled phase 3 trial of the safety and tolerability of IC51, an inactivated Japanese encephalitis vaccine.
    Tauber E; Kollaritsch H; von Sonnenburg F; Lademann M; Jilma B; Firbas C; Jelinek T; Beckett C; Knobloch J; McBride WJ; Schuller E; Kaltenböck A; Sun W; Lyons A
    J Infect Dis; 2008 Aug; 198(4):493-9. PubMed ID: 18588481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new inactivated Japanese encephalitis vaccine for adult travelers.
    Toovey S
    Travel Med Infect Dis; 2009 Sep; 7(5):301-4. PubMed ID: 19747666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Vero cell-derived, inactivated, SA14-14-2 strain-based vaccine (Ixiaro) for prevention of Japanese encephalitis.
    Erra EO; Kantele A
    Expert Rev Vaccines; 2015; 14(9):1167-79. PubMed ID: 26162529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recommendations for use of a booster dose of inactivated vero cell culture-derived Japanese encephalitis vaccine: advisory committee on immunization practices, 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 May; 60(20):661-3. PubMed ID: 21617632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IXIARO updated: overview of clinical trials and developments with the inactivated vaccine against Japanese encephalitis.
    Jelinek T
    Expert Rev Vaccines; 2013 Aug; 12(8):859-69. PubMed ID: 23984958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of mouse-brain inactivated Nakayama strain Japanese encephalitis vaccine--results from 30 years experience in Taiwan.
    Yang SE; Pan MJ; Tseng HF; Liau MY
    Vaccine; 2006 Mar; 24(14):2669-73. PubMed ID: 16314007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Japanese encephalitis: new options for active immunization.
    Halstead SB; Thomas SJ
    Clin Infect Dis; 2010 Apr; 50(8):1155-64. PubMed ID: 20218889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IC51 Japanese encephalitis vaccine.
    Kollaritsch H; Paulke-Korinek M; Dubischar-Kastner K
    Expert Opin Biol Ther; 2009 Jul; 9(7):921-31. PubMed ID: 19527110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A large-scale study on the safety and epidemiological efficacy of Japanese encephalitis (JE) live vaccine (SA14-14-2) in the JE endemic areas].
    Zhou B; Jia L; Xu X
    Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Feb; 20(1):38-41. PubMed ID: 10682513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety analysis of a Vero-cell culture derived Japanese encephalitis vaccine, IXIARO (IC51), in 6 months of follow-up.
    Dubischar-Kastner K; Kaltenboeck A; Klingler A; Jilma B; Schuller E
    Vaccine; 2010 Sep; 28(39):6463-9. PubMed ID: 20673824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.